Key Points
-
Trypanosoma brucei, T. cruzi and Leishmania spp. parasites are early branching eukaryotes that cause disease mainly in tropical countries. T. brucei synthesizes fatty acids (FAs) de novo. While bloodstream forms make myristate (C14) for glycosylphosphatidylinositol (GPI) anchors of their variant surface glycoprotein (which mediate antigenic variation), procyclic forms make mainly stearate (C18).
-
Rather than a conventional type I or II FA synthase, T. brucei uses a coenzyme A (CoA)-dependent microsomal FA elongase (ELO) pathway for most of its de novo synthesis. In other eukaryotes, the ELO pathway simply lengthens already long fatty acyl-CoAs. The T. brucei mitochondrial type II synthase is more specialized and makes octanoate (C8), a lipoic-acid precursor, as well as longer FAs up to C16.
-
While TbELO1–3 elongate C4 primer to C18, TbELO4 functions as a polyunsaturated FA ELO that lengthens arachidonate (C20:4) salvaged from the host. In addition to TbELO1–4 orthologues, L. major has desaturases and an extra polyunsaturated FA (PUFA) ELO needed to synthesize C22:5n-6 and C22:6n-3 from C18. By contrast, the two trypanosomes seem to have lost the portion of their PUFA pathway that converts 18:2n-6 to 20:4n-6 and 20:5n-3.
-
T. cruzi and Leishmania spp. have additional TbELO1–3 homologues that are probably involved in synthesis of the very-long-chain saturated acyl and alkyl groups that are found on surface GPI anchors and glycoconjugates. These GPIs, depending on the fatty chain length and degree of saturation, are involved in immunity and inflammation in different life-cycle stages. The selective regulation of the various ELOs could explain how these parasites produce the various FAs needed during different life-cycle stages, as happens in T. brucei.
-
Other eukaryotic parasitic protozoans such as the mucosal parasites and apicomplexans use mechanisms apparently dissimilar to those in trypanosomatids to make or acquire their bulk FAs.
-
Trypanosomatid mitochondrial type II and ELO pathways are apparently essential for parasite survival and could serve as potential drug targets.
-
The ELO pathway seems to have evolved to accommodate the complex and parasitic life-style of the trypanosomatids, allowing it to produce the different FAs that are needed as it migrates between different compartments in the vector and host.
Abstract
Most cells use either a type I or type II synthase to make fatty acids. Trypanosoma brucei, the sleeping sickness parasite, provides the first example of a third mechanism for this process. Trypanosomes use microsomal elongases to synthesize fatty acids de novo, whereas other cells use elongases to make long-chain fatty acids even longer. The modular nature of the pathway allows synthesis of different fatty-acid end products, which have important roles in trypanosome biology. Indeed, this newly discovered mechanism seems ideally suited for the parasitic lifestyle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Opperdoes, F. R. Compartmentation of carbohydrate metabolism in trypanosomes. Annu. Rev. Microbiol. 41, 127–151 (1987).
Lee, S. H., Stephens, J. L., Paul, K. S. & Englund, P. T. Fatty acid synthesis by elongases in trypanosomes. Cell 126, 691–699 (2006). Reported biochemical evidence for de novo synthesis of FAs by the ELO pathway in T. brucei.
Paul, K. S., Jiang, D., Morita, Y. S. & Englund, P. T. Fatty acid synthesis in African trypanosomes: a solution to the myristate mystery. Trends Parasitol. 17, 381–387 (2001). Summarizes the importance of myristate to T. brucei biology and reviews FA synthesis and other aspects of lipid metabolism.
van Hellemond, J. J. & Tielens, A. G. Adaptations in the lipid metabolism of the protozoan parasite Trypanosoma brucei. FEBS Lett. 580, 5552–5558 (2006).
Grab, D. J. et al. African trypanosome interactions with an in vitro model of the human blood–brain barrier. J. Parasitol. 90, 970–979 (2004).
Besteiro, S., Barrett, M. P., Riviere, L. & Bringaud, F. Energy generation in insect stages of Trypanosoma brucei: metabolism in flux. Trends Parasitol. 21, 185–191 (2005).
Dixon, H., Ginger, C. D. & Williamson, J. The lipid metabolism of blood and culture forms of Trypanosoma lewisi and Trypanosoma rhodesiense. Comp. Biochem. Physiol. B 39, 247–266 (1971).
Mellors, A. & Samad, A. The acquisition of lipids by African trypanosomes. Parasitol. Today 5, 239–244 (1989).
Voorheis, H. P. Fatty acid uptake by bloodstream forms of Trypanosoma brucei and other species of the kinetoplastida. Mol. Biochem. Parasitol. 1, 177–186 (1980).
Dixon, H. & Williamson, J. The lipid composition of blood and culture forms of Trypanosoma lewisi and Trypanosoma rhodesiense compared with that of their environment. Comp. Biochem. Physiol. 33, 111–128 (1970).
Coppens, I., Baudhuin, P., Opperdoes, F. R. & Courtoy, P. J. Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite. Proc. Natl Acad. Sci. USA 85, 6753–6757 (1988).
Coppens, I., Opperdoes, F. R., Courtoy, P. J. & Baudhuin, P. Receptor-mediated endocytosis in the bloodstream form of Trypanosoma brucei. J. Protozool. 34, 465–473 (1987).
Green, H. P., Del Pilar Molina Portela, M., St Jean, E. N., Lugli, E. B. & Raper, J. Evidence for a Trypanosoma brucei lipoprotein scavenger receptor. J. Biol. Chem. 278, 422–427 (2003).
Coppens, I., Levade, T. & Courtoy, P. J. Host plasma low density lipoprotein particles as an essential source of lipids for the bloodstream forms of Trypanosoma brucei. J. Biol. Chem. 270, 5736–5741 (1995).
Gilbert, R. J., Klein, R. A. & Miller, P. G. The role of threonine in the metabolism of acetyl coenzyme A by T rypanosoma brucei brucei. Comp. Biochem. Physiol. B 74, 277–281 (1983).
Donelson, J. E. Antigenic variation and the African trypanosome genome. Acta Trop. 85, 391–404 (2003).
Ferguson, M. A. & Cross, G. A. Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J. Biol. Chem. 259, 3011–3015 (1984).
Morita, Y. S., Paul, K. S. & Englund, P. T. Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors. Science 288, 140–143 (2000). The first report of FA synthesis by BSF T. brucei that also describes the different end products of synthesis by BSFs and PCFs.
Cross, G. A., Klein, R. A. & Linstead, D. J. Utilization of amino acids by Trypanosoma brucei in culture: L-threonine as a precursor for acetate. Parasitology 71, 311–326 (1975).
Smith, S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J. 8, 1248–1259 (1994).
Rock, C. O. & Jackowski, S. Forty years of bacterial fatty acid synthesis. Biochem. Biophys. Res. Commun. 292, 1155–1166 (2002).
Toke, D. A. & Martin, C. E. Isolation and characterization of a gene affecting fatty acid elongation in Saccharomyces cerevisiae. J. Biol. Chem. 271, 18413–18422 (1996).
Kohlwein, S. D. et al. Tsc13p is required for fatty acid elongation and localizes to a novel structure at the nuclear-vacuolar interface in Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 109–125 (2001).
Oh, C. S., Toke, D. A., Mandala, S. & Martin, C. E. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation. J. Biol. Chem. 272, 17376–17384 (1997).
Han, G. et al. The Saccharomyces cerevisiae YBR159W gene encodes the 3-ketoreductase of the microsomal fatty acid elongase. J. Biol. Chem. 277, 35440–35449 (2002).
Jakobsson, A., Westerberg, R. & Jacobsson, A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog. Lipid Res. 45, 237–249 (2006).
Leonard, A. E., Pereira, S. L., Sprecher, H. & Huang, Y. S. Elongation of long-chain fatty acids. Prog. Lipid Res. 43, 36–54 (2004). Reviews the different types of FA elongation, including that of PUFAs.
Zank, T. K. et al. Cloning and functional characterisation of an enzyme involved in the elongation of δ6-polyunsaturated fatty acids from the moss Physcomitrella patens. Plant J. 31, 255–268 (2002).
Paul, S. et al. Members of the Arabidopsis FAE1-like 3-ketoacyl-CoA synthase gene family substitute for the Elop proteins of Saccharomyces cerevisiae. J. Biol. Chem. 281, 9018–9029 (2006).
Steiger, R. F. & Steiger, E. Cultivation of Leishmania donovani and Leishmania braziliensis in defined media: nutritional requirements. J. Protozool. 24, 437–441 (1977).
Petrini, G. A., Altabe, S. G. & Uttaro, A. D. Trypanosoma brucei oleate desaturase may use a cytochrome b5-like domain in another desaturase as an electron donor. Eur. J. Biochem. 271, 1079–1086 (2004).
Tripodi, K. E., Buttigliero, L. V., Altabe, S. G. & Uttaro, A. D. Functional characterization of front-end desaturases from trypanosomatids depicts the first polyunsaturated fatty acid biosynthetic pathway from a parasitic protozoan. FEBS J. 273, 271–280 (2006). Reports the specificities of L. major, T. cruzi and T. brucei PUFA desaturases and predicts the pathways present in trypanosomatids.
Patnaik, P. K. et al. Molecular species analysis of phospholipids from Trypanosoma brucei bloodstream and procyclic forms. Mol. Biochem. Parasitol. 58, 97–105 (1993).
Oliveira, M. M., Timm, S. L. & Costa, S. C. Lipid composition of Trypanosoma cruzi. Comp. Biochem. Physiol. B 58, 195–199 (1977).
Venkatesan, S. & Ormerod, W. E. Lipid content of the slender and stumpy forms of Trypanosoma brucei rhodesiense: a comparative study. Comp. Biochem. Physiol. B 53, 481–487 (1976).
Livore, V. I., Tripodi, K. E. & Uttaro, A. D. Elongation of polyunsaturated fatty acids in trypanosomatids. FEBS J. 274, 264–274 (2007).
Doering, T. L., Pessin, M. S., Hart, G. W., Raben, D. M. & Englund, P. T. The fatty acids in unremodelled trypanosome glycosyl-phosphatidylinositols. Biochem.J. 299, 741–746 (1994).
Ferguson, M. A. The surface glycoconjugates of trypanosomatid parasites. Philos. Trans. R. Soc. Lond. B. 352, 1295–1302 (1997). Reviews the structures of abundant trypanosomatid cell-surface GPI anchors and glycoconjugates.
Opperdoes, F. R. Localization of the initial steps in alkoxyphospholipid biosynthesis in glycosomes (microbodies) of Trypanosoma brucei. FEBS Lett. 169, 35–39 (1984).
Opperdoes, F. R. & Szikora, J. P. In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes. Mol. Biochem. Parasitol. 147, 193–206 (2006).
Zomer, A. W., Opperdoes, F. R. & van den Bosch, H. Alkyl dihydroxyacetone phosphate synthase in glycosomes of Trypanosoma brucei. Biochim. Biophys. Acta 1257, 167–173 (1995).
Heise, N. & Opperdoes, F. R. The dihydroxyacetonephosphate pathway for biosynthesis of ether lipids in Leishmania mexicana promastigotes. Mol. Biochem. Parasitol. 89, 61–72 (1997).
Martin, K. L. & Smith, T. K. Phosphatidylinositol synthesis is essential in bloodstream form Trypanosoma brucei. Biochem. J. 396, 287–295 (2006).
Schofield, L. & Hackett, F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177, 145–153 (1993).
Magez, S. et al. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160, 1949–1956 (1998).
Camargo, M. M. et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158, 5890–5901 (1997). Shows that the unsaturated fatty groups in the GPI anchor are essential for the pro-inflammatory activity of T. cruzi mucin.
de Veer, M. J. et al. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 33, 2822–2831 (2003).
Campos, M. A. et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167, 416–423 (2001).
Oliveira, A. C. et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 173, 5688–5696 (2004).
Gazzinelli, R. T. & Denkers, E. Y. Protozoan encounters with Toll-like receptor signalling pathwayssss: implications for host parasitism. Nature Rev. Immunol. 6, 895–906 (2006).
Almeida, I. C. & Gazzinelli, R. T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 70, 467–477 (2001).
Almeida, I. C. et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19, 1476–1485 (2000).
Doering, T. L. et al. Trypanosome metabolism of myristate, the fatty acid required for the variant surface glycoprotein membrane anchor. J. Biol. Chem. 268, 9215–9222 (1993).
Florin-Christensen, M. et al. Temperature acclimation of Trypanosoma cruzi epimastigote and metacyclic trypomastigote lipids. Mol. Biochem. Parasitol. 88, 25–33 (1997).
Das, S. et al. Lipid metabolism in mucous-dwelling amitochondriate protozoa. Int. J. Parasitol. 32, 655–675 (2002).
Beach, D. H., Holz, G. G. Jr, Singh, B. N. & Lindmark, D. G. Fatty acid and sterol metabolism of cultured Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 38, 175–190 (1990).
White, S. W., Zheng, J., Zhang, Y. M. & Rock, C. O. The structural biology of type II fatty acid biosynthesis. Annu. Rev. Biochem. 74, 791–831 (2005).
Waller, R. F. et al. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc. Natl Acad. Sci. USA 95, 12352–12357 (1998).
Mazumdar, J., E, H. W., Masek, K., C, A. H. & Striepen, B. Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii. Proc. Natl Acad. Sci. USA 103, 13192–13197 (2006).
Surolia, A., Ramya, T. N., Ramya, V. & Surolia, N. 'FAS't inhibition of malaria. Biochem. J. 383, 401–412 (2004).
Gunther, S., McMillan, P. J., Wallace, L. J. & Muller, S. Plasmodium falciparum possesses organelle-specific α-keto acid dehydrogenase complexes and lipoylation pathways. Biochem. Soc. Trans. 33, 977–980 (2005).
Wrenger, C. & Muller, S. The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways. Mol. Microbiol. 53, 103–113 (2004).
Zhu, G., Keithly, J. S. & Philippe, H. What is the phylogenetic position of Cryptosporidium? Int. J. Syst. Evol. Microbiol. 50, 1673–1681 (2000).
Zhu, G. Current progress in the fatty acid metabolism in Cryptosporidium parvum. J. Eukaryot. Microbiol. 51, 381–388 (2004).
Crawford, M. J., Zhu, G. & Roos, D. S. Both Type I and Type II fatty acid synthases in Toxoplasma gondii. Molecular Parasitology Meeting XIV, Abstract 14C (2003).
Zhu, G., Marchewka, M. J., Woods, K. M., Upton, S. J. & Keithly, J. S. Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum. Mol. Biochem. Parasitol. 105, 253–260 (2000).
Stephens, J. L., Lee, S. H., Paul, K. S. & Englund, P. T. Mitochondrial fatty acid synthesis in Trypansoma brucei. J. Biol. Chem. 282, 4427–4436 (2007). The first report showing the role of mitochondrial type II FA synthesis in a trypanosomatid.
van Weelden, S. W., van Hellemond, J. J., Opperdoes, F. R. & Tielens, A. G. New functions for parts of the Krebs cycle in procyclic Trypanosoma brucei, a cycle not operating as a cycle. J. Biol. Chem. 280, 12451–12460 (2005). In addition to showing the disjointed role of the Kreb's cycle in T. brucei , this work presents an overview of T. brucei metabolism.
Brody, S., Oh, C., Hoja, U. & Schweizer, E. Mitochondrial acyl carrier protein is involved in lipoic acid synthesis in Saccharomyces cerevisiae. FEBS Lett. 408, 217–220 (1997).
Zhang, L., Joshi, A. K., Hofmann, J., Schweizer, E. & Smith, S. Cloning, expression, and characterization of the human mitochondrial β-ketoacyl synthase. Complementation of the yeast CEM1 knock-out strain. J. Biol. Chem. 280, 12422–12429 (2005).
Wada, H., Shintani, D. & Ohlrogge, J. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. Proc. Natl Acad. Sci. USA 94, 1591–1596 (1997).
Rawsthorne, S. Carbon flux and fatty acid synthesis in plants. Prog. Lipid Res. 41, 182–196 (2002).
Gueguen, V., Macherel, D., Jaquinod, M., Douce, R. & Bourguignon, J. Fatty acid and lipoic acid biosynthesis in higher plant mitochondria. J. Biol. Chem. 275, 5016–5025 (2000).
Shintani, D. K. & Ohlrogge, J. B. The characterization of a mitochondrial acyl carrier protein isoform isolated from Arabidopsis thaliana. Plant Physiol. 104, 1221–1229 (1994).
Mikolajczyk, S. & Brody, S. De novo fatty acid synthesis mediated by acyl-carrier protein in Neurospora crassa mitochondria. Eur. J. Biochem. 187, 431–437 (1990).
Zensen, R., Husmann, H., Schneider, R., Peine, T. & Weiss, H. De novo synthesis and desaturation of fatty acids at the mitochondrial acyl-carrier protein, a subunit of NADH:ubiquinone oxidoreductase in Neurospora crassa. FEBS Lett. 310, 179–181 (1992).
Schneider, F. & Cassagne, C. Specific inhibition of plant fatty acid elongation by a long-chain cerulenin analogue. Eur. J. Biochem. 228, 704–709 (1995).
Paul, K. S., Bacchi, C. J. & Englund, P. T. Multiple triclosan targets in Trypanosoma brucei. Eukaryot. Cell 3, 855–861 (2004).
Simpson, A. G., Stevens, J. R. & Lukes, J. The evolution and diversity of kinetoplastid flagellates. Trends Parasitol. 22, 168–174 (2006). Presents recent thoughts on the evolution of trypanosomatids.
Waller, R. F., McConville, M. J. & McFadden, G. I. More plastids in human parasites? Trends Parasitol. 20, 54–57 (2004).
El-Sayed, N. M. et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 309, 404–409 (2005).
Baldauf, S. L., Roger, A. J., Wenk-Siefert, I. & Doolittle, W. F. A kingdom-level phylogeny of eukaryotes based on combined protein data. Science 290, 972–977 (2000).
Worsham, L. M., Williams, S. G. & Ernst-Fonberg, M. L. Early catalytic steps of Euglena gracilis chloroplast type II fatty acid synthase. Biochim. Biophys. Acta 1170, 62–71 (1993).
Leander, B. S. Did trypanosomatid parasites have photosynthetic ancestors? Trends Microbiol. 12, 251–258 (2004).
Hoffmeister, M., Piotrowski, M., Nowitzki, U. & Martin, W. Mitochondrial trans-2-enoyl-CoA reductase of wax ester fermentation from Euglena gracilis defines a new family of enzymes involved in lipid synthesis. J. Biol. Chem. 280, 4329–4338 (2005).
Thuillier-Bruston, F., Briand, J. & Laval-Martin, D. Effects of a first exposure to ethanol on the compositions of neutral and polar lipids in Euglena gracilis Z, taken as a hepatic cell model: equilibration by citrulline-malate. Biochem. Med. Metab. Biol. 44, 159–174 (1990).
Ilg, T. et al. Structure of Leishmania mexicana lipophosphoglycan. J. Biol. Chem. 267, 6834–6840 (1992).
Nomura, S., Horiuchi, T., Hata, T. & Omura, S. Inhibition of sterol and fatty acid biosyntheses by cerulenin in cell-free systems of yeast. J. Antibiot. (Tokyo) 25, 365–368 (1972).
Hayashi, T., Yamamoto, O., Sasaki, H., Kawaguchi, A. & Okazaki, H. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli. Biochem. Biophys. Res. Commun. 115, 1108–1113 (1983).
McMurry, L. M., Oethinger, M. & Levy, S. B. Triclosan targets lipid synthesis. Nature 394, 531–532 (1998).
Banerjee, A. et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227–230 (1994).
Hogenauer, G. & Woisetschlager, M. A diazaborine derivative inhibits lipopolysaccharide biosynthesis. Nature 293, 662–664 (1981).
Zhang, Y. M. et al. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites. J. Biol. Chem. 279, 50969–50975 (2004).
Jones, S. M. et al. Analogues of thiolactomycin as potential antimalarial agents. J. Med. Chem. 48, 5932–5941 (2005).
Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358–361 (2006).
Ondeyka, J. G. et al. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy. J. Nat. Prod. 69, 377–380 (2006).
Gilbert, R. & Klein, R. A. Carnitine stimulates ATP synthesis in Trypanosoma brucei brucei. FEBS Lett. 141, 271–274 (1982).
Klein, R. A., Angus, J. M. & Waterhouse, A. E. Carnitine in Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 6, 93–110 (1982).
Kumar, S., Tamura, K. & Nei, M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform. 5, 150–163 (2004).
Pays, E. et al. The trypanolytic factor of human serum. Nature Rev. Microbiol. 4, 477–486 (2006).
Acknowledgements
We would like to thank S. Beverley, R. Gazzinelli, D. Hanasekaran, J. Lukes, Y. Morita, K. Paul, J. Pevsner, S. Prigge, D. Roos, J. Samuelson and S. Subramanian for discussions. We would also like to thank R. Gazzinelli and A. Uttaro for sharing unpublished manuscripts. We are grateful to G. Yildirir and other members of our laboratory for support. Work in the authors' laboratory has been supported by a grant from the US National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
FURTHER INFORMATION
GeneDB: Trypanosoma brucei genome
TIGR Database: Entamoeba histolytica Genome Project
Glossary
- Glycosome
-
An organelle, related to peroxisomes, found in trypanosomatid protozoans that contain enzymes of the glycolytic and other metabolic pathways.
- Glycosylphosphatidylinositol
-
(GPI). A glycolipid, covalently linked to the C terminus of many eukaryotic proteins, which anchors them to the plasma membrane. Some polysaccharides, such as lipophosphoglycan (LPG) in Leishmania spp., are also GPI anchored.
- Primer
-
A short, pre-existing acyl group that initiates chain growth in FA synthesis.
- Phosphopantetheine
-
A component of CoA or a prosthetic group of ACP; during FA synthesis the growing acyl chain is thioesterified to the phosphopantetheine sulphydryl group.
- HXXH amino-acid motif
-
A sequence, composed of two histidines (H) and two non-conserved amino acids (X), that is found in FA ELOs.
- Epimastigote, promastigote and trypomastigote
-
Life-cycle stages of trypanosomatid protozoans that differ morphologically in the positioning of the flagellum.
- Jaccard clustering
-
An algorithm for grouping highly related proteins.
- Ceramide
-
A molecule composed of sphingosine and an FA that forms the lipid moiety of some GPI anchors and the phospholipid sphingomyelin.
Rights and permissions
About this article
Cite this article
Lee, S., Stephens, J. & Englund, P. A fatty-acid synthesis mechanism specialized for parasitism. Nat Rev Microbiol 5, 287–297 (2007). https://doi.org/10.1038/nrmicro1617
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1617
This article is cited by
-
In silico prediction of the metabolism of Blastocrithidia nonstop, a trypanosomatid with non-canonical genetic code
BMC Genomics (2024)
-
Genome-wide analysis reveals allelic variation and chromosome copy number variation in paromomycin-resistant Leishmania donovani
Parasitology Research (2022)
-
Fatty acid elongation by ELOVL condensing enzymes depends on a histidine nucleophile
Nature Structural & Molecular Biology (2021)
-
The structural basis of fatty acid elongation by the ELOVL elongases
Nature Structural & Molecular Biology (2021)
-
Evolution of metabolic capabilities and molecular features of diplonemids, kinetoplastids, and euglenids
BMC Biology (2020)